Market Cap 9.89B
Revenue (ttm) 3.58B
Net Income (ttm) 456.00M
EPS (ttm) N/A
PE Ratio 25.17
Forward PE 25.44
Profit Margin 12.74%
Debt to Equity Ratio 0.19
Volume 3,493,600
Avg Vol 2,564,462
Day's Range N/A - N/A
Shares Out 834.67M
Stochastic %K 91%
Beta 0.25
Analysts Hold
Price Target $15.17

Company Profile

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. Its Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeuti...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 91 40 4900 2900
Address:
8-2-337, Road No. 3, Banjara Hills, Hyderabad, India
Invescent
Invescent Jul. 24 at 1:35 PM
📊 Today's Trade Ideas 1️⃣ $RDY Momentum Setup • 68% Entry: $11.74 - $11.97 Target: $12.51 Stop: $11.33 Risk: Medium 2️⃣ $JGRO Momentum Setup • 54% Entry: $92.74 - $93.80 Target: $98.80 Stop: $89.48 Risk: High 3️⃣ $HALO Watchlist Setup • 44% Entry: $80.44 - $81.19 Target: $85.69 Stop: $77.61 Risk: Low Not financial advice.
0 · Reply
Aleexandder
Aleexandder Jul. 23 at 6:30 PM
$RDY Biosimilars are a long-term growth area as expensive biologic drugs lose exclusivity...
0 · Reply
EarningsInsider
EarningsInsider Jul. 22 at 3:31 PM
https://www.marketbeat.com/earnings/reports/2026-7-22-dr-reddys-laboratories-limited-stock/ $RDY Dr. Reddy's Laboratories Earnings Transcr
0 · Reply
Robby83
Robby83 Jul. 21 at 7:40 PM
$COYA my only ticker not seeing big green... weird seeing SP so heavily tied to $RDY .
0 · Reply
InItToWinIt100
InItToWinIt100 Jun. 26 at 1:39 PM
$UNH Nice 5 pt pop! $RDY Up 1.5% so far
0 · Reply
InItToWinIt100
InItToWinIt100 Jun. 26 at 1:38 PM
Are you $RDY ?
0 · Reply
InItToWinIt100
InItToWinIt100 Jun. 26 at 2:21 AM
Watchlist for 6/26: $GRPN $AAPL $UNH $RDY $TII
1 · Reply
BillionerOfKing
BillionerOfKing Jun. 23 at 5:33 PM
$RDY Current Stock Price: $14.12 Contracts to trade: $15.0 RDY Jul 17 2026 Call Entry: $0.09 Exit: $0.13 ROI: 48% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
briefingcom
briefingcom May. 18 at 12:36 PM
$RDY: Dr. Reddy's launches its generic semaglutide injection in Canada https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20260518061903RDY&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page
0 · Reply
AlertsAndNews
AlertsAndNews May. 16 at 7:46 PM
$RDY $NVO Dr. Reddy's Laboratories Launches its Generic Semaglutide Injection in Canada "The launch follows Dr. Reddy's receipt of the Notice of Compliance (NOC) from Health Canada on April 28th, 2026, marking the company's readiness to serve Canadian patients Dr. Reddy's is the first company to receive Health Canada approval for generic Semaglutide Injection in Canada"
1 · Reply
Latest News on RDY
Dr Reddy’s gets USFDA nod for Rituximab biosimilar

2026-08-01T14:05:18.000Z - 3 days ago

Dr Reddy’s gets USFDA nod for Rituximab biosimilar


Indian drugmaker Dr Reddy's slips on margin, semaglutide supply woes

Wed, 22 Jul 2026 23:55:45 -0400 - 12 days ago

Indian drugmaker Dr Reddy's slips on margin, semaglutide supply woes


Dr. Reddy's Laboratories Enters Oversold Territory (RDY)

2026-07-22T20:49:42.000Z - 12 days ago

Dr. Reddy's Laboratories Enters Oversold Territory (RDY)


Dr. Reddy's Laboratories Q1 Earnings Call Highlights

Wed, 22 Jul 2026 13:07:23 -0400 - 12 days ago

Dr. Reddy's Laboratories Q1 Earnings Call Highlights


Dr. Reddy's Laboratories Transcript: Q1 26/27

Jul 22, 2026, 10:00 AM EDT - 13 days ago

Dr. Reddy's Laboratories Transcript: Q1 26/27


Dr. Reddy's Laboratories Quarterly report: Q1 2027

Jul 22, 2026, 10:00 AM EDT - 13 days ago

Dr. Reddy's Laboratories Quarterly report: Q1 2027


Dr. Reddy's Laboratories Slides: Q1 2027

Jul 22, 2026, 10:00 AM EDT - 13 days ago

Dr. Reddy's Laboratories Slides: Q1 2027


Indian drugmaker Dr Reddy's posts quarterly profit slump

Wed, 22 Jul 2026 06:53:43 -0400 - 13 days ago

Indian drugmaker Dr Reddy's posts quarterly profit slump


Dr. Reddy's (RDY) Set to Release Q1 Earnings on July 22

2026-07-21T17:56:37.000Z - 13 days ago

Dr. Reddy's (RDY) Set to Release Q1 Earnings on July 22


Dr. Reddy's Laboratories Transcript: Investor update

Jul 9, 2026, 7:00 AM EDT - 26 days ago

Dr. Reddy's Laboratories Transcript: Investor update


Dr. Reddy’s Generic Ozempic Supplies Delayed on API Issue

2026-07-09T10:48:22.000Z - 26 days ago

Dr. Reddy’s Generic Ozempic Supplies Delayed on API Issue


Dr Reddy's delays semaglutide supply due to active ingredient issue

Thu, 09 Jul 2026 00:54:39 -0400 - 26 days ago

Dr Reddy's delays semaglutide supply due to active ingredient issue


Bullish Two Hundred Day Moving Average Cross - RDY

2026-06-22T20:12:40.000Z - 6 weeks ago

Bullish Two Hundred Day Moving Average Cross - RDY


Dr. Reddy’s launches generic Semaglutide injection in Canada

2026-05-17T15:45:31.000Z - 2 months ago

Dr. Reddy’s launches generic Semaglutide injection in Canada


Dr. Reddy's Laboratories Transcript: Q4 25/26

May 12, 2026, 10:00 AM EDT - 3 months ago

Dr. Reddy's Laboratories Transcript: Q4 25/26


Dr. Reddy's Laboratories Quarterly report: Q4 2026

May 12, 2026, 10:00 AM EDT - 3 months ago

Dr. Reddy's Laboratories Quarterly report: Q4 2026


Dr. Reddy's Laboratories Slides: Q4 2026

May 12, 2026, 10:00 AM EDT - 3 months ago

Dr. Reddy's Laboratories Slides: Q4 2026


Dr. Reddy's Laboratories Annual report: Q4 2026

May 12, 2026, 10:00 AM EDT - 3 months ago

Dr. Reddy's Laboratories Annual report: Q4 2026


Dr. Reddy's Laboratories Annual report: Q4 2026

May 12, 2026, 10:00 AM EDT - 3 months ago

Dr. Reddy's Laboratories Annual report: Q4 2026


Indian drugmaker Dr. Reddy's posts quarterly profit slump

May 12, 2026, 7:16 AM EDT - 3 months ago

Indian drugmaker Dr. Reddy's posts quarterly profit slump


Dr. Reddy’s downgraded to Sell from Neutral at Goldman Sachs

2026-04-23T17:41:31.000Z - 3 months ago

Dr. Reddy’s downgraded to Sell from Neutral at Goldman Sachs


Dr. Reddy’s rally on CNBC report overstates upside, says Citi

2026-04-23T16:00:42.000Z - 3 months ago

Dr. Reddy’s rally on CNBC report overstates upside, says Citi


Dr. Reddy’s reports FDA acceptance to review Abatacept BLA

2026-02-20T16:00:22.000Z - 5 months ago

Dr. Reddy’s reports FDA acceptance to review Abatacept BLA


Dr. Reddy's Laboratories Transcript: Q3 25/26

Jan 21, 2026, 9:00 AM EST - 6 months ago

Dr. Reddy's Laboratories Transcript: Q3 25/26


Dr. Reddy's Laboratories Quarterly report: Q3 2026

Jan 21, 2026, 9:00 AM EST - 6 months ago

Dr. Reddy's Laboratories Quarterly report: Q3 2026


Dr. Reddy's Laboratories Slides: Q3 2026

Jan 21, 2026, 9:00 AM EST - 6 months ago

Dr. Reddy's Laboratories Slides: Q3 2026


Dr. Reddy's Laboratories Transcript: Q2 25/26

Oct 24, 2025, 10:00 AM EDT - 10 months ago

Dr. Reddy's Laboratories Transcript: Q2 25/26


Dr. Reddy's Laboratories Quarterly report: Q2 2026

Oct 24, 2025, 10:00 AM EDT - 10 months ago

Dr. Reddy's Laboratories Quarterly report: Q2 2026


Dr. Reddy's Laboratories Slides: Q2 2026

Oct 24, 2025, 10:00 AM EDT - 10 months ago

Dr. Reddy's Laboratories Slides: Q2 2026


Dr. Reddy's Q1FY26 Financial Results

Jul 23, 2025, 1:46 PM EDT - 1 year ago

Dr. Reddy's Q1FY26 Financial Results


Dr. Reddy's Laboratories Transcript: Q1 25/26

Jul 23, 2025, 10:00 AM EDT - 1 year ago

Dr. Reddy's Laboratories Transcript: Q1 25/26


Dr. Reddy's Laboratories Quarterly report: Q1 2026

Jul 23, 2025, 10:00 AM EDT - 1 year ago

Dr. Reddy's Laboratories Quarterly report: Q1 2026


Dr. Reddy's Laboratories Slides: Q1 2026

Jul 23, 2025, 10:00 AM EDT - 1 year ago

Dr. Reddy's Laboratories Slides: Q1 2026


Dr. Reddy's Q4 & Full Year FY25 Financial Results

May 9, 2025, 2:53 PM EDT - 1 year ago

Dr. Reddy's Q4 & Full Year FY25 Financial Results


Dr. Reddy's Laboratories Transcript: Q4 24/25

May 9, 2025, 10:00 AM EDT - 1 year ago

Dr. Reddy's Laboratories Transcript: Q4 24/25


Dr. Reddy's Laboratories Annual report: Q4 2025

May 9, 2025, 10:00 AM EDT - 1 year ago

Dr. Reddy's Laboratories Annual report: Q4 2025


Dr. Reddy's Laboratories Slides: Q4 2025

May 9, 2025, 10:00 AM EDT - 1 year ago

Dr. Reddy's Laboratories Slides: Q4 2025


Dr. Reddy's Laboratories Annual report: Q4 2025

May 9, 2025, 10:00 AM EDT - 1 year ago

Dr. Reddy's Laboratories Annual report: Q4 2025


Dr. Reddy's Q3 & 9MFY25 Financial Results

Jan 23, 2025, 12:35 PM EST - 1 year ago

Dr. Reddy's Q3 & 9MFY25 Financial Results


Dr. Reddy's Laboratories Transcript: Q3 24/25

Jan 23, 2025, 9:00 AM EST - 1 year ago

Dr. Reddy's Laboratories Transcript: Q3 24/25


Dr. Reddy's Laboratories Quarterly report: Q3 2025

Jan 23, 2025, 9:00 AM EST - 1 year ago

Dr. Reddy's Laboratories Quarterly report: Q3 2025


Dr. Reddy's Q2 & H1FY25 Financial Results

Nov 5, 2024, 9:59 AM EST - 1 year ago

Dr. Reddy's Q2 & H1FY25 Financial Results


Dr. Reddy's Laboratories Transcript: Q2 24/25

Nov 5, 2024, 9:00 AM EST - 1 year ago

Dr. Reddy's Laboratories Transcript: Q2 24/25


Dr. Reddy's Laboratories Quarterly report: Q2 2025

Nov 5, 2024, 9:00 AM EST - 1 year ago

Dr. Reddy's Laboratories Quarterly report: Q2 2025


Dr. Reddy's Laboratories: India 'will be our number one market'

Jul 30, 2024, 8:25 PM EDT - 2 years ago

Dr. Reddy's Laboratories: India 'will be our number one market'


Dr. Reddy's Q1FY25 Financial Results

Jul 27, 2024, 9:51 AM EDT - 2 years ago

Dr. Reddy's Q1FY25 Financial Results


Dr. Reddy's Laboratories Transcript: Q1 24/25

Jul 27, 2024, 7:00 AM EDT - 2 years ago

Dr. Reddy's Laboratories Transcript: Q1 24/25


Dr. Reddy's Laboratories Quarterly report: Q1 2025

Jul 27, 2024, 7:00 AM EDT - 2 years ago

Dr. Reddy's Laboratories Quarterly report: Q1 2025


Dr. Reddy's Laboratories Transcript: M&A Announcement

Jun 26, 2024, 9:30 AM EDT - 2 years ago

Dr. Reddy's Laboratories Transcript: M&A Announcement


Dr. Reddy's Laboratories Press release: M&A Announcement

Jun 26, 2024, 9:30 AM EDT - 2 years ago

Dr. Reddy's Laboratories Press release: M&A Announcement


Dr. Reddy's Laboratories Slides: Investor presentation

Jun 1, 2024, 6:30 AM EDT - 2 years ago

Dr. Reddy's Laboratories Slides: Investor presentation


Dr. Reddy's Q4 & Full Year FY24 Financial Results

May 7, 2024, 10:31 AM EDT - 2 years ago

Dr. Reddy's Q4 & Full Year FY24 Financial Results


Dr. Reddy's Laboratories Transcript: Q4 23/24

May 7, 2024, 10:00 AM EDT - 2 years ago

Dr. Reddy's Laboratories Transcript: Q4 23/24


Dr. Reddy's Laboratories Quarterly report: Q4 2024

May 7, 2024, 10:00 AM EDT - 2 years ago

Dr. Reddy's Laboratories Quarterly report: Q4 2024


Dr. Reddy's Laboratories Annual report: Q4 2024

May 7, 2024, 10:00 AM EDT - 2 years ago

Dr. Reddy's Laboratories Annual report: Q4 2024


Invescent
Invescent Jul. 24 at 1:35 PM
📊 Today's Trade Ideas 1️⃣ $RDY Momentum Setup • 68% Entry: $11.74 - $11.97 Target: $12.51 Stop: $11.33 Risk: Medium 2️⃣ $JGRO Momentum Setup • 54% Entry: $92.74 - $93.80 Target: $98.80 Stop: $89.48 Risk: High 3️⃣ $HALO Watchlist Setup • 44% Entry: $80.44 - $81.19 Target: $85.69 Stop: $77.61 Risk: Low Not financial advice.
0 · Reply
Aleexandder
Aleexandder Jul. 23 at 6:30 PM
$RDY Biosimilars are a long-term growth area as expensive biologic drugs lose exclusivity...
0 · Reply
EarningsInsider
EarningsInsider Jul. 22 at 3:31 PM
https://www.marketbeat.com/earnings/reports/2026-7-22-dr-reddys-laboratories-limited-stock/ $RDY Dr. Reddy's Laboratories Earnings Transcr
0 · Reply
Robby83
Robby83 Jul. 21 at 7:40 PM
$COYA my only ticker not seeing big green... weird seeing SP so heavily tied to $RDY .
0 · Reply
InItToWinIt100
InItToWinIt100 Jun. 26 at 1:39 PM
$UNH Nice 5 pt pop! $RDY Up 1.5% so far
0 · Reply
InItToWinIt100
InItToWinIt100 Jun. 26 at 1:38 PM
Are you $RDY ?
0 · Reply
InItToWinIt100
InItToWinIt100 Jun. 26 at 2:21 AM
Watchlist for 6/26: $GRPN $AAPL $UNH $RDY $TII
1 · Reply
BillionerOfKing
BillionerOfKing Jun. 23 at 5:33 PM
$RDY Current Stock Price: $14.12 Contracts to trade: $15.0 RDY Jul 17 2026 Call Entry: $0.09 Exit: $0.13 ROI: 48% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
briefingcom
briefingcom May. 18 at 12:36 PM
$RDY: Dr. Reddy's launches its generic semaglutide injection in Canada https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20260518061903RDY&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page
0 · Reply
AlertsAndNews
AlertsAndNews May. 16 at 7:46 PM
$RDY $NVO Dr. Reddy's Laboratories Launches its Generic Semaglutide Injection in Canada "The launch follows Dr. Reddy's receipt of the Notice of Compliance (NOC) from Health Canada on April 28th, 2026, marking the company's readiness to serve Canadian patients Dr. Reddy's is the first company to receive Health Canada approval for generic Semaglutide Injection in Canada"
1 · Reply
MarketBeat
MarketBeat May. 14 at 12:11 PM
https://marketbeat.com/a/8654460/ $RDY Dr. Reddy's Laboratories Q4 Earnings Call Highlights
0 · Reply
EarningsInsider
EarningsInsider May. 12 at 9:21 PM
https://www.marketbeat.com/earnings/reports/2026-5-12-dr-reddys-laboratories-limited-stock/ $RDY Dr. Reddy's Laboratories Earnings Transcr
0 · Reply
ontariomark
ontariomark May. 12 at 6:53 PM
$RDY News: Dr. Reddy’s to sell Ozempic generics in Canada in days (RDY)
0 · Reply
SuperGreenToday
SuperGreenToday May. 12 at 2:20 PM
$RDY Share Price: $12.34 Contract Selected: Dec 18, 2026 $12.5 Calls Buy Zone: $2.68 – $3.31 Target Zone: $4.58 – $5.60 Potential Upside: 62% ROI Time to Expiration: 219 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
CapitalMonk
CapitalMonk May. 12 at 10:54 AM
$RDY Price: $13.14 (-0.68%) Trend: Bearish Market Bias (7D): Bullish Bias 📈 Expected Range: ±1.88% RSI: 56.8 | Momentum: Moderate Volume: +21.1% vs avg Volatility: 1.96% Support: $12.77 | Resistance: $14.20 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25
0 · Reply
MStocktwit
MStocktwit Apr. 30 at 5:20 PM
$NVO $RDY $LLY Exact copy from the Novo with different branded label. Better than a Generic. Approved last year. Plosbrio (identical to Ozempic) Poviztra (identical to Wegovy)
0 · Reply
Gnomsayin
Gnomsayin Apr. 29 at 7:48 PM
0 · Reply
MStocktwit
MStocktwit Apr. 29 at 6:02 PM
$NVO $RDY $LLY Novo changes the label and you have the generic ready to go. Source http://www.endorhealth.com/article/generic-ozempic-coming-to-canada#:~:text=Eli%20Lilly%20has%20stated%20it,rebranded%20versions%20on%20December%2022%3A
0 · Reply
MStocktwit
MStocktwit Apr. 29 at 5:48 PM
$NVO $RDY $LLY In December 2025, Health Canada approved two Novo Nordisk rebranded versions on December 22: Plosbrio (identical to Ozempic) Poviztra (identical to Wegovy)
0 · Reply
ForestFoxes
ForestFoxes Apr. 29 at 5:29 PM
$LLY $NVO $RDY Dr. Reddy's Laboratories (RDY) is strongly connected with Coya Therapeutics $COYA through a strategic partnership, licensing agreement, and financial investment 🙂
0 · Reply
Ro_Patel
Ro_Patel Apr. 29 at 5:26 PM
Health Canada approves $RDY generic version of $NVO Ozempic (patent expired in January) Canada is the first in the G7 forum to approve a generic version of the treatment Also, reviewing 8 other submissions for generic GLP-1 treatments & expects to make regulatory decisions in the coming weeks & months Some generic medications in Canada can be 45% to 90% cheaper than their brand name equivalents A monthly supply of Ozempic or Wegovy costs b/n $300-$400 — sometimes even more depending on the dose A recent survey suggested about 3M Canadian adults are currently taking GLP-1 drugs, such as Ozempic or Mounjaro, and that many more would like to, but cost is a barrier. $LLY
0 · Reply